Effect of mode of delivery of patient reported outcomes in patients with breast disease: a randomised controlled trial

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(Karakatsanis Andreas) > Effect of mode of d...

LIBRIS Formathandbok (Information om MARC21)

Fältnamn	Indikatorer	Metadata
000		04501naa a2200433 4500
001		oai:DiVA.org:uu-522869
003		SwePub
008		240216s2024 \| \|\|\|\|\|\|\|\|\|\|\|000 \|\|eng\|
024	7	a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5228692 URI
024	7	a https://doi.org/10.1097/JS9.00000000000008152 DOI
040		a (SwePub)uu
041		a engb eng
042		9 SwePub
072	7	a ref2 swepub-contenttype
072	7	a art2 swepub-publicationtype
100	1	a Pantiora, Eiriniu Uppsala universitet,Endokrinkirurgi4 aut0 (Swepub:uu)eirpa377
245	1 0	a Effect of mode of delivery of patient reported outcomes in patients with breast disease :b a randomised controlled trial
264	1	b Lippincott Williams & Wilkins,c 2024
338		a electronic2 rdacarrier
500		a De två första författarna delar förstaförfattarskapet.De två sista författarna delar sistaförfattarskapet.
520		a Background: Patient reported outcomes (PROs) have an integral role on how to improve patients' overall experience. The optimal PROs delivery in patients with breast disease is an important issue since PROs are steadily integrated in routine care.Methods: An institutional phase 3 randomised controlled, open-label trial. Eligible candidates were adult women with perceived or confirmed breast disease. Computer generated randomization was used to allocate interventions: collection of PROs in electronic or paper form. Our objective was the effectiveness of electronic versus paper form of PROs. The main outcome measures were: response rate, reported experience, administrative resources, and carbon dioxide emissions.Results: Two hundred thirty-eight patients were randomised. After loss-to-follow-up and consent withdrawals, 218 participants (median age, IQR=55, 21; n=110/n=108) were included in the per-intention-to-treat analysis. Response rate was 61.8% for electronic patient reported outcomes (ePROs) and 63.9% for paper patient reported outcomes (pPROs) (difference=-2.1%, 95% CI: -15.8-11.7%). Only known breast cancer at recruitment was predictive for response in multivariable analysis. ePROs were associated with a 57% reduction in administrative time required, a 95% reduction in incremental costs, and 84% reduction in carbon dioxide emissions, all differences being significant. No difference was detected in perception of PRO significance or ease of completion, but participants experienced that they needed less time to complete ePROs [median, (IQR) 10 (9) respectively 15(10)]. Finally, respondents would prefer ePROs over pPROs (difference 48.1%, 95% CI: 32.8-63.4%).Conclusion: ePROs do not increase the response rate in patients with perceived or confirmed breast disease. However, they can enhance patient experience, reduce incremental costs, facilitate administrative logistics, and are more sustainable. On the basis of these findings, both modalities should continue to be available.
650	7	a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kirurgi0 (SwePub)302122 hsv//swe
650	7	a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Surgery0 (SwePub)302122 hsv//eng
653		a electronic patient reported outcomes-measures (ePROs)
653		a paper patient reported outcomes-meausres (pPROs)
653		a response rate
653		a perceived or confirmed breast disease
653		a randomised controlled trial
700	1	a Hedman, Lia-Chasmineu Uppsala universitet,Institutionen för kirurgiska vetenskaper4 aut
700	1	a Aristokleous, Ilianau Uppsala universitet,Plastikkirurgi4 aut0 (Swepub:uu)iliar511
700	1	a Sjökvist, Oliviau Uppsala universitet,Plastikkirurgi4 aut0 (Swepub:uu)olisj248
700	1	a Karakatsanis, Andreasu Uppsala universitet,Endokrinkirurgi4 aut0 (Swepub:uu)andka774
700	1	a Schiza, Aglaiau Uppsala universitet,Science for Life Laboratory, SciLifeLab,Cancerimmunterapi,Department of Oncology, Uppsala University Hospital, Uppsala, Sweden.4 aut0 (Swepub:uu)aglma952
710	2	a Uppsala universitetb Endokrinkirurgi4 org
773	0	t International Journal of Surgeryd : Lippincott Williams & Wilkinsg 110:1, s. 176-182q 110:1<176-182x 1743-9191x 1743-9159
856	4	u https://doi.org/10.1097/JS9.0000000000000815y Fulltext
856	4	u https://uu.diva-portal.org/smash/get/diva2:1838430/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
856	4 8	u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-522869
856	4 8	u https://doi.org/10.1097/JS9.0000000000000815

Hitta via bibliotek

International Journal of Surgery (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...: Pantiora, Eirini; Hedman, Lia-Chas ...; Aristokleous, Il ...; Sjökvist, Olivia; Karakatsanis, An ...; Schiza, Aglaia

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Kirurgi

Artiklar i publikationen: International Jo ...

Av lärosätet: Uppsala universitet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se